The Pharma Data

NOVEMBER 26, 2020

This novel nanoparticle formation technology provides hope for improving the possibilities and probabilities of developing better medicines for patients and it expands Nanoform’s reach into the growing biological market. ” Prof. ” Prof. Finnish time. About Nanoform.

Containment 52

Containment Medicine Bioavailability Clinical Trials 52

The Pharma Data

JANUARY 3, 2021

The information in the press release is information that Nanoform is obliged to make public pursuant to the EU Market Abuse Regulation. Nanoform works together with pharma and biotech partners globally to provide hope for patients in developing new and improved medicines utilizing Nanoform’s platform technologies. Finnish time.

Containment 52

Containment Bioavailability Clinical Trials Clinical Trials 52

The Pharma Data

DECEMBER 3, 2020

Achieving the primary endpoint of the SOLSTICE trial is an exciting new development in the search for a treatment for transplant recipients with refractory/resistant CMV infection. No new safety signals were identified and maribavir was associated with lower incidence of neutropenia compared to IAT. About Maribavir.

Drugs 52

Drugs Medicine Trials Containment 52

Drug Discovery World

OCTOBER 25, 2023

JV: A key bottleneck in the research and development of a drug is the lengthy experimentation that is required to gain the confidence to run clinical trials. VeriSIM Life has developed a hybrid biosimulation and AI-based platform that can assess the likely success of drug candidates, similar to a credit score.

Drugs 111

Drugs Pharma Companies Clinical Trials Clinical Trials 111

Pharmaceutical Technology

NOVEMBER 24, 2022

Few contract development and manufacturing organizations (CDMOs) are able to provide radiolabeling services as part of a fully integrated pharmaceutical development program. How does your unique Synthesis-to-Clinic® offering streamline the drug development process? How are human ADME studies designed?

Bioavailability 130

Bioavailability Manufacturing Drugs Production 130

The Pharma Data

JANUARY 27, 2021

Development of oral biosensor and contract development & manufacturing. Psychedelic transdermal and sublingual drug formulation development. Vektor will position itself for commercial manufacturing, pipeline development and drug formulations for critical mental health conditions.

Drugs 52

Drugs Manufacturing Drug Delivery Production 52

Pharmaceutical Technology

FEBRUARY 3, 2023

Additionally, OSD manufacturing approaches are well developed, with processes that ensure a repeatable distribution of ingredients, uniformity in dissolution, and bioavailability, which verify that the drug product is safe and effective.

Contamination 130

Contamination Manufacturing Containment Production 130